2024 annual financial data
AbCellera Biologics 2024 Operating margin
AbCellera Biologics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -1,091.69%.
Operating income was -314,766,000 USD and net income was -162,857,000 USD.
Operating cash flow was -108,556,000 USD.
Get free AbCellera Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 28,833,000 USD
- Operating income
- -314,766,000 USD
- Net income
- -162,857,000 USD
- Operating cash flow
- -108,556,000 USD